Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OHR Pharmaceutical Inc (NASDAQ:OHRP)

3.16
Delayed Data
As of May 25
 +0.05 / +1.61%
Today’s Change
2.02
Today|||52-Week Range
6.56
-48.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2009

2010

2011

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.0020.4K83.5K1.2M
 
 
 
 
 
Operating ExpensesGross Income0.00-20.4K-83.5K-1.2M
 
 
 
 
General Expenses932.9K995.1K1.2M16.3M
 
 
 
 
 
Research And Development0.00234.4K522.0K8.8M
 
 
 
 
Total Operating Expenses932.9K1.0M1.2M17.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-932.9K-1.0M-1.2M-17.5M
 
 
 
 
 
Extraordinary Credit64.4K1.5M49.2K2.6M
 
 
 
 
 
Extraordinary Charge0.000.00-4.0M-338.9K
 
 
 
Interest Expense On Debt25.8K21.5K2.4K6.0K
 
 
 
 
 
Other Expenses29.8K50.9K72.2K-24.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-864.4K494.4K-5.1M-15.2M
 
 
 
 
 
Net Income-864.4K494.4K-5.1M-15.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.4M10.9M12.9M28.4M
 
 
 
 
 
Shares To Calculate EPS Diluted8.4M10.9M12.9M28.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09$0.06-$0.39-$0.54
 
 
 
 
 
EPS Diluted-$0.09$0.06-$0.39-$0.54